Kliks S C, Halstead S B
J Virol. 1983 May;46(2):394-404. doi: 10.1128/JVI.46.2.394-404.1983.
Chicken antisera to Murray Valley encephalitis (MVE) virus, when incubated with virus and assayed for plaques on chicken embryo (CE) monolayers, neutralized MVE virus at high concentrations of antibody, but caused increases in plaque counts at low concentrations of antibody. Plaque enhancement did not occur when the same virus-antibody mixtures were assayed on a continuous line of rhesus monkey kidney cells (LLC-MK2), nor when the anti-MVE antibody was of mammalian origin and the assay system was CE monolayers. Correspondingly, chicken anti-MVE did not enhance the plaque formation of MVE virus in a stable line of mouse macrophages, P-388D1, whereas rabbit and mouse anti-MVE did enhance plaque formation. This enhancing activity was associated with noncytophilic immunoglobulin G (IgG). The Fc terminus of the IgG molecule was required, as no plaque enhancement occurred with chicken anti-MVE Fab. These data indicate that there is a requirement for taxonomic complementarity between Fc termini and Fc receptors in the above systems. CE cell monolayers were found to contain approximately 2% of Fc receptor-bearing cells among the fibroblast-like cells. Fc receptor-bearing cells in CE monolayers were isolated and found to be of the mononuclear phagocytic lineage. These mononuclear phagocytes, which originate in lymphoid tissues and blood associated with CE tissue fragments, are integrated into primary CE monolayers and form infectious centers in the presence of virus and low dilutions of antibody.
针对墨累谷脑炎(MVE)病毒的鸡抗血清,在与病毒孵育并在鸡胚(CE)单层细胞上检测蚀斑时,在高浓度抗体时可中和MVE病毒,但在低浓度抗体时会导致蚀斑计数增加。当在恒河猴肾细胞系(LLC-MK2)上检测相同的病毒-抗体混合物时,不会出现蚀斑增强现象;当抗MVE抗体来源于哺乳动物且检测系统为CE单层细胞时,也不会出现蚀斑增强现象。相应地,鸡抗MVE抗体在稳定的小鼠巨噬细胞系P-388D1中不会增强MVE病毒的蚀斑形成,而兔抗MVE和小鼠抗MVE抗体会增强蚀斑形成。这种增强活性与非亲细胞性免疫球蛋白G(IgG)相关。IgG分子的Fc末端是必需的,因为鸡抗MVE Fab不会出现蚀斑增强现象。这些数据表明,在上述系统中,Fc末端和Fc受体之间需要分类学互补性。发现CE细胞单层在成纤维细胞样细胞中约有2%的细胞带有Fc受体。分离出CE单层中带有Fc受体的细胞,发现它们属于单核吞噬细胞谱系。这些单核吞噬细胞起源于与CE组织碎片相关的淋巴组织和血液,整合到原代CE单层细胞中,并在有病毒和低稀释度抗体存在时形成感染中心。